CX Institutional’s Regency Centers REG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
3,436
+348
+11% +$27.3K 0.01% 669
2026
Q1
$234K Buy
3,088
+807
+35% +$60.1K 0.01% 678
2025
Q4
$157K Buy
2,281
+472
+26% +$33.1K ﹤0.01% 766
2025
Q3
$132K Buy
1,809
+114
+7% +$8.13K ﹤0.01% 783
2025
Q2
$121K Buy
1,695
+43
+3% +$3.07K ﹤0.01% 736
2025
Q1
$122K Buy
+1,652
New +$120K ﹤0.01% 715
2022
Q3
Sell
-324
Closed -$19K 985
2022
Q2
$19K Buy
+324
New +$21.5K ﹤0.01% 854
2021
Q4
Sell
-321
Closed -$22K 782
2021
Q3
$22K Buy
321
+46
+17% +$3.05K ﹤0.01% 728
2021
Q2
$18K Buy
275
+57
+26% +$3.6K ﹤0.01% 760
2021
Q1
$12K Buy
218
+45
+26% +$2.34K ﹤0.01% 749
2020
Q4
$8K Buy
173
+149
+621% +$6.41K ﹤0.01% 756
2020
Q3
$1K Buy
24
+1
+4% +$41 ﹤0.01% 862
2020
Q2
$1K Sell
23
-64
-74% -$2.7K ﹤0.01% 827
2020
Q1
$3K Buy
87
+77
+770% +$4.43K ﹤0.01% 628
2019
Q4
$1K Sell
10
-38
-79% -$2.5K ﹤0.01% 722
2019
Q3
$3K Sell
48
-39
-45% -$2.6K ﹤0.01% 688
2019
Q2
$6K Buy
87
+51
+142% +$3.43K ﹤0.01% 588
2019
Q1
$2K Buy
+36
New +$2.3K ﹤0.01% 702

Other funds holding REG

CX Institutional's REG Position: Q2 2026 in Review

CX Institutional increased its Regency Centers (REG) stake by 11% in Q2 2026, buying an estimated $27.3K and bringing the position to 3,436 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #669.

CX Institutional first reported a position in REG in Q1 2019 and has held it in 18 quarters since. 61 funds tracked by Wall St. Rank hold REG as of Q2 2026.

  • CX Institutional held 3,436 shares of Regency Centers worth $274K as of Q2 2026.
  • CX Institutional bought 348 Regency Centers shares in Q2 2026, an estimated $27.3K.
  • Regency Centers made up 0.01% of CX Institutional's portfolio in Q2 2026, its #669 holding.
  • CX Institutional first reported a position in Regency Centers in Q1 2019 and has held it in 18 quarters since.
  • 61 funds tracked by Wall St. Rank held Regency Centers as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.